Growing number of clinical trials conducted worldwide makes it imperative to maintain clinical data in a format that is easily readable and accessible.
For instance, as per the data published by Clinicaltrials.gov in 2022 data, there are around 423,514 clinical trials listed with locations in all 50 States and 221 countries to date.
Thus, to manage vast amounts of data, companies are concentrating more on developing sophisticated and user-friendly software that can lessen the load of massive amounts of data produced by clinical trials.
Furthermore, the healthcare sector is undergoing a digital revolution in both developed and emerging nations, which is hastening the uptake of technologies like electronic trial master files, thereby fostering the market growth.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The market size of electronic trial master file reached USD 1.2 billion in 2023 and is set to cross USD 2.8 billion by 2032, due to the technological advancements in systems, along with the increasing government funding for clinical trials.
The services segment dominated the market with a revenue of USD 697.1 million in 2023, owing to the introduction of customized and integrated services that seamlessly incorporate eTMF platforms with other clinical trial management systems (CTMS), electronic data capture (EDC) systems, and regulatory submission platforms.
North America market share was over 48.1% of the revenue share in 2023, attributed to the presence of a well-established healthcare infrastructure, high adoption rates of advanced technologies, and a strong emphasis on regulatory compliance.